Materia Medica
Lavender
Lavandula angustifolia
Lavender is an aromatic Mediterranean shrub whose flowers and essential oil are used for nervous tension, sleep and digestion, and on the skin for bites and minor wounds. Its oil is rich in linalool and linalyl acetate, and an oral lavender-oil capsule has been tested for anxiety.
What Is Lavender?
Lavender is a small aromatic shrub of the Mediterranean, grown for its fragrant purple flower spikes and the essential oil distilled from them. Herbalists use it as a calming nervine, a remedy for a nervous stomach, and a skin application for bites, burns and minor wounds.
Lavandula angustifolia is native to the Mediterranean region and is cultivated there and elsewhere for lavender oil 35,
The oil is rich in linalool and linalyl acetate 32Reference 32Oil of lavender (Lavandula angustifolia Mill.). An oral capsule of the oil, sold as Silexan, has been tested for anxiety in several placebo-controlled trials 1,
Several other lavenders are grown for oil. Spike lavender (L. latifolia) and the hybrid lavandin (L. × intermedia) carry more camphor and 1,8-cineole than true lavender 33Reference 33ReviewBiological activities of lavender essential oil — review.
How Is Lavender Used?
Lavender is taken as a tea or tincture, inhaled or applied as essential oil, and swallowed as a standardized oil capsule.
- Dried flower tea — a mild evening infusion for tension, restlessness and sleep, and for a bloated, uneasy stomach.
- Tincture or 1:2 liquid extract — the Western herbal preparations of the flower.
- Essential oil, inhaled — in aromatherapy for sleep and relaxation 12,
13Reference 12Meta-analysisThe sleep-enhancing effect of lavender essential oil in adults — a systematic review and meta-analysisView study →Reference 13Meta-analysisEffects of aromatherapy on sleep quality in older adults — a meta-analysisView study → . - Essential oil, applied — diluted on the skin for insect bites, rashes, burns and minor wounds.
- Oral lavender-oil capsules — the standardized preparation Silexan, 80–160 mg/day, used for anxiety 1,
2, .5Reference 1RCTSilexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder — randomized, double-blind, placebo-controlled trialView study →Reference 2RCTLavender oil preparation Silexan is effective in generalized anxiety disorder — a randomized, double-blind comparison to placebo and paroxetineView study →Reference 5RCTSilexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set — randomized controlled trialView study →
Traditional Uses
Western Herbal Medicine
The part used is the flower, the dried flowering spike, taken as an infusion or a tincture, or distilled to an essential oil.
Western practice treats lavender first as a nervine. It is given for nervous tension, restlessness, anxiety, tension headache and insomnia, usually as a mild evening tea or as a few drops of oil.
Its second use is as a carminative, for bloating, wind and colic. Western herbalism treats this as a nervous stomach, the same tension expressed in the gut.
The third use is topical: the oil is applied to burns, insect bites, rashes and minor wounds as an antiseptic and a healing agent. It is also used for period pain and premenstrual tension.
Indications
- Anxiety and nervous tension [oral lavender-oil capsule; flower tea and tincture]
- Sleep problems linked to anxiety [oral lavender-oil capsule; inhaled oil] Caution: In the capsule trials, sleep improved almost entirely as a result of reduced anxiety. The aromatherapy trials are small and of limited quality 11,
12 . - Low mood that comes with anxiety [oral lavender-oil capsule] Caution: The trials were in people with anxiety. There is no trial in major depression as the main diagnosis 4,
10 . - Tension headache and restlessness [flower; Western herbal use]
- Bloating, wind and colic [flower; Western herbal use]
- Period pain and premenstrual tension [flower and oil; Western herbal use]
- Insect bites, rashes, sunburn and minor burns [essential oil, applied]
- Minor skin infections [essential oil, applied]
Botany
Lavender is a small, bushy shrub in the mint family (Lamiaceae), usually 30–60 cm tall and 60–90 cm wide in gardens 35Reference 35Lavandula angustifolia (English lavender) — plant profile — NC State Extension Gardener Plant ToolboxView study →. It can reach 1–1.5 m 36Reference 36Hedge, I. C. Lavandula angustifolia Mill. — species description and distribution — flora. In Flora of Pakistan, Labiatae. http://www.efloras.org/florataxon.aspx?flora_id=5&taxon_id=200019757View study →. Its stems are square and hairy 35Reference 35Lavandula angustifolia (English lavender) — plant profile — NC State Extension Gardener Plant ToolboxView study →.
The leaves are narrow and linear, up to 5 cm long and 2–5 mm wide, with rolled-under edges. They are grey-green and covered in tiny star-shaped hairs 35,
The flowers grow in whorls of six to ten, gathered into a spike about 2–5 cm long at the end of a long bare stalk. The calyx is tubular and 13-ribbed. The corolla is two-lipped, 8–12 mm long, and blue-purple, though pink and white forms are grown 35,
Distribution
Lavender grows wild in the Mediterranean region, including France, Italy and Spain, and is cultivated there for its oil 35,
It needs full sun and very well-drained, rather dry, neutral to alkaline soil, and tolerates sandy and shallow rocky ground 35Reference 35Lavandula angustifolia (English lavender) — plant profile — NC State Extension Gardener Plant ToolboxView study →.
Growing Conditions
Cultivation snapshot for Lavender
ZoneUSDA 5–9 35Reference 35Lavandula angustifolia (English lavender) — plant profile — NC State Extension Gardener Plant ToolboxView study →.
Waterdry to medium; well-drained, alkaline soil is essential — root rot is the main failure mode in wet conditions.
Habitbenefits from a spring shape-prune and a hard cutback (to ~8”) every 3 years to control size and promote vigorous new growth.
Grow it yourself
Farm Wiki is our cultivation-focused sister site, also run by Justin Cooke.
Pharmacology & Research
Most of the human research on lavender concerns one preparation, Silexan, a standardized oral capsule of steam-distilled Lavandula angustifolia oil taken at 80–160 mg/day 1,
A 2023 meta-analysis pooled the five placebo-controlled trials at 80 mg/day (1,213 patients) in subthreshold anxiety, generalized anxiety disorder and mixed anxiety and depression 7Reference 7Meta-analysisEfficacy of Silexan in patients with anxiety disorders — a meta-analysis of randomized, placebo-controlled trialsView study →. In head-to-head trials Silexan matched lorazepam 3Reference 3RCTA multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder — randomized controlled trialView study → and outperformed placebo in a trial where paroxetine only showed a trend 2Reference 2RCTLavender oil preparation Silexan is effective in generalized anxiety disorder — a randomized, double-blind comparison to placebo and paroxetineView study →. It caused no withdrawal symptoms when stopped abruptly 8Reference 8RCTSilexan does not cause withdrawal symptoms even when abruptly discontinued — randomized controlled trialView study →.
Sleep, mood, pain, spasm, microbial and neuroprotective effects rest on inhaled aromatherapy trials, or on animal and in-vitro work with the oil and with linalool and linalyl acetate 11,
-
Best-supported: oral Silexan reduces symptoms in generalized and subthreshold anxiety across multiple RCTs and meta-analyses, with results comparable to lorazepam and better than placebo where paroxetine only trended 1,
2, .3, 4, 5, 6, 7Reference 1RCTSilexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder — randomized, double-blind, placebo-controlled trialView study →Reference 2RCTLavender oil preparation Silexan is effective in generalized anxiety disorder — a randomized, double-blind comparison to placebo and paroxetineView study →Reference 3RCTA multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder — randomized controlled trialView study →Reference 4RCTEfficacy of Silexan in mixed anxiety–depression — a randomized, placebo-controlled trialView study →Reference 5RCTSilexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set — randomized controlled trialView study →Reference 6Meta-analysisEfficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders — network meta-analysisView study →Reference 7Meta-analysisEfficacy of Silexan in patients with anxiety disorders — a meta-analysis of randomized, placebo-controlled trialsView study → -
Emerging, worth watching: improvement in sleep and in co-occurring depressive symptoms, so far mostly as a result of reduced anxiety rather than as a primary effect 10,
11, .12, 13Reference 10Meta-analysisBeneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety — meta-analysisView study →Reference 11ReviewEffect of the anxiolytic drug silexan on sleep — a narrative reviewView study →Reference 12Meta-analysisThe sleep-enhancing effect of lavender essential oil in adults — a systematic review and meta-analysisView study →Reference 13Meta-analysisEffects of aromatherapy on sleep quality in older adults — a meta-analysisView study → -
Mechanistically thin: anti-inflammatory, analgesic, antispasmodic and antimicrobial actions are shown in animals and in vitro but have little or no controlled human data, and rest largely on the isolated constituents 17,
18, .19, 20, 21Reference 17AnimalAnti-inflammatory activity of linalool and linalyl acetate constituents of essential oils — rat modelView study →Reference 18AnimalInvolvement of adenosine A1 and A2A receptors in (−)-linalool-induced antinociception — animal modelView study →Reference 19AnimalEffects of (−)-linalool in the acute hyperalgesia induced by carrageenan, L-glutamate and prostaglandin E2 — rat modelView study →Reference 20In vitroLinalyl acetate as a major ingredient of lavender essential oil relaxes the rabbit/rat smooth muscle — in vitro/animal modelView study →Reference 21In vitroStudies on the mode of action of the essential oil of lavender (Lavandula angustifolia) — in vitro smooth-muscle studyView study → - The caveat: the strong anxiety evidence is specific to a standardized oral essential-oil capsule; it does not carry over to the tincture, the tea, or aromatherapy.
The clinical evidence belongs to concentrated essential oil, not to the dried flower. The anxiety trials used an oral oil capsule, and the sleep trials used essential oil as aromatherapy. The tea and the tincture have not been tested in controlled trials.
1. Anxiety
Silexan at 80 mg/day beat placebo on the Hamilton Anxiety scale in 221 adults with subthreshold (“not otherwise specified”) anxiety over ten weeks. Response rates were 76.9% against 49.1%, and sleep quality improved as well 1Reference 1RCTSilexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder — randomized, double-blind, placebo-controlled trialView study →.
In 539 adults with generalized anxiety disorder, 80 and 160 mg/day both beat placebo over ten weeks, while 20 mg/day of paroxetine showed only a trend in the main analysis 2Reference 2RCTLavender oil preparation Silexan is effective in generalized anxiety disorder — a randomized, double-blind comparison to placebo and paroxetineView study →. In a six-week trial against lorazepam, anxiety scores fell by a similar amount on both (45% and 46%) 3Reference 3RCTA multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder — randomized controlled trialView study →.
A pooled analysis of 925 patients with generalized anxiety disorder found 160 mg/day superior to placebo on every outcome, and suggested that 80 mg/day is the lower end of the effective range 5Reference 5RCTSilexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set — randomized controlled trialView study →.
A 2019 network meta-analysis and a 2023 meta-analysis of the five placebo-controlled trials both confirmed the anxiety-reducing effect 6,
These results come from one manufacturer’s standardized oral capsule. The anxiolytic dose is a concentrated swallowed essential oil, not an aromatherapy diffuser, a tea or a 1:2 tincture.
Gap: all positive anxiety data are for oral Silexan; there is no equivalent controlled evidence for the tincture or dried-flower tea at the doses people actually use.
2. Sleep Quality
In the Silexan trials, sleep improved along with anxiety. A mediation analysis found that more than 98% of the effect on sleep came through the reduction in anxiety, and the direct effect on sleep was marginal 11Reference 11ReviewEffect of the anxiolytic drug silexan on sleep — a narrative reviewView study →.
Separately, a 2026 meta-analysis of eleven RCTs (628 adults) found that lavender essential oil improved sleep quality, while noting that the number and quality of the studies were limited 12Reference 12Meta-analysisThe sleep-enhancing effect of lavender essential oil in adults — a systematic review and meta-analysisView study →. A 2024 meta-analysis of aromatherapy in older adults found improved sleep quality, with lavender alone giving the largest effect 13Reference 13Meta-analysisEffects of aromatherapy on sleep quality in older adults — a meta-analysisView study →. Blinding is difficult in these trials, because the scent is obvious.
Gap: no trial shows lavender working as a primary sleep aid on objective sleep measures; the aromatherapy evidence is subjective, and the oral-capsule benefit comes through reduced anxiety.
3. Depressive Symptoms
A 2023 meta-analysis of the five placebo-controlled trials found that Silexan reduced co-occurring depressive symptoms in patients with subthreshold anxiety or anxiety disorders, with larger improvements in those with more severe symptoms 10Reference 10Meta-analysisBeneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety — meta-analysisView study →. A dedicated RCT in 318 people with mixed anxiety and depression showed benefit on both anxiety and depression scores 4Reference 4RCTEfficacy of Silexan in mixed anxiety–depression — a randomized, placebo-controlled trialView study →.
No trial has tested Silexan in major depressive disorder as the main diagnosis.
Gap: the effect is on depressive symptoms that come with anxiety; lavender has not been tested as a stand-alone antidepressant in diagnosed major depression.
4. Anti-Inflammatory
Linalool and linalyl acetate reduced carrageenan-induced paw swelling in rats. Linalool was the more active; linalyl acetate acted later and more weakly, as if it were converted to linalool first 17Reference 17AnimalAnti-inflammatory activity of linalool and linalyl acetate constituents of essential oils — rat modelView study →.
In macrophage cells, linalool reduced nitric-oxide production 31Reference 31In vitroPeana, A. T., et al. (2006). (−)-Linalool inhibits in vitro NO formation: probable involvement in the antinociceptive activity — in vitro/animal model. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/16137709/View study →, and its pain-relieving effect in mice involves adenosine receptors 18Reference 18AnimalInvolvement of adenosine A1 and A2A receptors in (−)-linalool-induced antinociception — animal modelView study →.
These are reproducible rodent and in-vitro findings with isolated compounds. No controlled human trial has tested lavender for an inflammatory condition.
5. Analgesic
Linalool relieved pain in rodent models, an effect partly blocked by adenosine A1 and A2A receptor antagonists 18Reference 18AnimalInvolvement of adenosine A1 and A2A receptors in (−)-linalool-induced antinociception — animal modelView study →. It reduced nitric-oxide formation 31Reference 31In vitroPeana, A. T., et al. (2006). (−)-Linalool inhibits in vitro NO formation: probable involvement in the antinociceptive activity — in vitro/animal model. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/16137709/View study →, and it blunted the heightened pain sensitivity caused by carrageenan and by glutamate in rats 19Reference 19AnimalEffects of (−)-linalool in the acute hyperalgesia induced by carrageenan, L-glutamate and prostaglandin E2 — rat modelView study →.
Inhaled lavender has been used in aromatherapy for pain around procedures and surgery, but the trials are hard to blind because the scent is obvious.
Gap: the mechanism is well described in rodents, but there are no well-controlled human data, and none for the tincture.
6. Antispasmodic
Lavender oil relaxed isolated guinea-pig ileum, apparently through cyclic AMP, and linalool acted in the same way as the whole oil. Earlier work had shown spasmolytic activity on rat uterus in vitro 21Reference 21In vitroStudies on the mode of action of the essential oil of lavender (Lavandula angustifolia) — in vitro smooth-muscle studyView study →. Linalyl acetate relaxed isolated rabbit artery, partly through nitric oxide and partly by dephosphorylating myosin light chain 20Reference 20In vitroLinalyl acetate as a major ingredient of lavender essential oil relaxes the rabbit/rat smooth muscle — in vitro/animal modelView study →.
All of this is isolated-tissue work; no clinical trial has tested lavender for menstrual, gut or other spasm.
Gap: no human trial has tested any spasm-related condition, including period pain.
7. Antimicrobial
Lavender essential oil shows antibacterial and antifungal activity in vitro, which is the pharmacology behind its topical use for minor skin infections. The activity is attributed to monoterpenes such as linalool and terpinen-4-ol, which disrupt microbial membranes.
Topical oil is the same preparation the laboratory data model. No controlled clinical trial has shown that the oil clears or prevents a skin infection in people.
8. Neuroprotective
Lavender oil at 100 mg/kg improved memory in mice given scopolamine, lowered acetylcholinesterase activity and oxidative-stress markers in the hippocampus, and protected cultured nerve cells from hydrogen peroxide 22Reference 22AnimalProtective effect of lavender oil on scopolamine-induced cognitive deficits in mice — animal modelView study →. In cell studies, the oil did not worsen three kinds of nerve-cell injury and improved survival after hydrogen-peroxide damage 15Reference 15In vitroExploring pharmacological mechanisms of lavender (Lavandula angustifolia) essential oil on central nervous system targets — in vitroView study →.
These are animal and cell studies, with no clinical data.
Mechanisms
The anxiety-reducing action of lavender oil has been studied mainly at serotonin targets. In mice, the effect of inhaled oil was blocked by a 5-HT1A antagonist but not by the GABA-A antagonist picrotoxin, and the oil did not bind the benzodiazepine site 16Reference 16AnimalAnxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABA-A/benzodiazepine neurotransmission — animal modelView study →. In healthy men, eight weeks of Silexan reduced serotonin-1A receptor binding on PET scans 14Reference 14RCTEffects of Silexan on the serotonin-1A receptor and microstructure of the human brain — a randomized, placebo-controlled PET studyView study →. In vitro, the oil and linalool bound the NMDA receptor and the serotonin transporter, but not the benzodiazepine receptor 15Reference 15In vitroExploring pharmacological mechanisms of lavender (Lavandula angustifolia) essential oil on central nervous system targets — in vitroView study →.
Linalool and linalyl acetate have also been studied for pain, inflammation and smooth-muscle relaxation, in animals and isolated tissue 17,
| Mechanism | Drives | Key compounds |
|---|---|---|
| 5-HT1A serotonin-receptor involvement (human PET; animal antagonist studies); no action at the benzodiazepine site 14, | anxietydepressive symptoms | whole essential oil, linalool |
| NMDA-receptor binding and serotonin-transporter inhibition (in vitro) 15Reference 15In vitroExploring pharmacological mechanisms of lavender (Lavandula angustifolia) essential oil on central nervous system targets — in vitroView study → | anxietydepressive symptoms | whole essential oil, linalool |
| Adenosine A1/A2A signalling + nitric-oxide suppression | analgesicanti-inflammatory | linalool |
| Oedema pathway ↓ | anti-inflammatory | linalool, linalyl acetate |
| cAMP-mediated smooth-muscle relaxation | antispasmodic | whole essential oil, linalool |
| Microbial membrane disruption | antimicrobial | linalool, terpinen-4-ol |
Clinical Trials
Lavender has a substantial trial programme, almost entirely for the oral Silexan preparation in anxiety and related mood and sleep symptoms. Other indications and other preparations remain preclinical.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| Five placebo-controlled Silexan trials, plus others (anxiety, mood, sleep) | ongoing(e.g. PTSD) | 0identified | ~40+(constituent & animal studies) |
Last checked: July 2026.
Phytochemistry
True lavender oil is dominated by linalool and linalyl acetate. Under the ISO standard, linalool makes up 25–38% of the oil and linalyl acetate 25–45% 32Reference 32Oil of lavender (Lavandula angustifolia Mill.).
Good lavender oil is low in camphor (at most 0.5%) and 1,8-cineole. Higher levels of either point to adulteration or a different species 32Reference 32Oil of lavender (Lavandula angustifolia Mill.).
Spike lavender (L. latifolia) and lavandin (L. × intermedia) oils carry much more camphor and 1,8-cineole than true lavender oil 33Reference 33ReviewBiological activities of lavender essential oil — review.
Other volatiles include terpinen-4-ol, the ocimenes, lavandulyl acetate and its alcohol lavandulol, myrtenol, and small amounts of caryophyllene, caryophyllene oxide and nerolidol 32,
The flower also carries a small non-volatile fraction, including the coumarins coumarin and herniarin and the triterpene ursolic acid 32Reference 32Oil of lavender (Lavandula angustifolia Mill.).
Constituent Summary
Figures are the ISO 3515 limits for Lavandula angustifolia oil, as a share of the oil; natural samples vary widely. † marks the compounds that should stay low in true lavender 32,
Monoterpene8 compounds7 with data
Sesquiterpene1 compoundno data
Anthocyanin1 compound1 with data
Dosage
In research, lavender is almost always given as the standardized oral essential-oil capsule Silexan, dosed in milligrams. The trials did not test the dried-flower tea or the tincture.
| Indication | Preparation | Dose | Est. dried-herb equivalent | Source |
|---|---|---|---|---|
| Anxiety (generalized or subthreshold) | Silexan oral essential-oil capsule | 80 mg/day; 160 mg/day in generalized anxiety disorder | — | 1, |
| Mixed anxiety and depression | Silexan oral capsule | 80 mg/day | — | 4Reference 4RCTEfficacy of Silexan in mixed anxiety–depression — a randomized, placebo-controlled trialView study → |
| Sleep (through reduced anxiety) | Silexan oral capsule | 80 mg/day | — | 11Reference 11ReviewEffect of the anxiolytic drug silexan on sleep — a narrative reviewView study → |
| Sleep (aromatherapy) | Inhaled essential oil | Varies by trial | Not applicable (inhaled) | 12, |
Traditional Dosage
| System | Preparation | Dose |
|---|---|---|
| Western herbal | Dried flower infusion (tea) | 1–2 tsp dried flower per cup, 1–3× daily |
| Western herbal | Liquid extract 1:2 | 15–30 mL / week |
| Western herbal | Tincture 1:5 (45%) | ~2–4 mL, up to 3× daily |
Safety & Pregnancy
Lavender is well tolerated by mouth and by inhalation. The main cautions concern the oil on the skin: it can cause contact allergy, and case reports have linked repeated use in children to breast growth.
- Well tolerated by mouth and inhaled. Side effects in the capsule trials were no more common than on placebo, apart from burping, and there was no withdrawal on stopping.
- Contact allergy. Topical lavender oil can sensitize the skin, and aged, oxidized oil is more sensitizing than fresh.
- Repeated skin use in children. Case reports link lavender products to breast growth in prepubertal children; the evidence for a link is weak, but repeated skin use in young children is best avoided.
- Sedative medicines. Adding lavender to sedative drugs could add to their effect; no such interaction has been shown.
- No drug-metabolism or contraceptive interaction. In healthy volunteers Silexan did not change the main drug-metabolising enzymes, and a trial found it did not affect an ethinylestradiol/levonorgestrel pill.
Full Safety & Interactions Detail
Tolerability. In the Silexan trials, adverse events were about as common as on placebo 2,
Contact allergy. Lavender oil is a recognized contact allergen, and its allergenic potential rises once linalool oxidizes on exposure to air, so aged oil is more sensitizing than fresh.
Breast growth in children. Case reports describe breast growth in prepubertal boys, and early breast development in girls, during repeated use of lavender-containing products, which resolved when the products were stopped 23,
On the other side, lavender oil applied to the skin of young rats showed no oestrogen-like activity 26Reference 26AnimalUterotrophic assay of percutaneous lavender oil in immature female rats — animal model (negative)View study →, and guideline testing of linalool and linalyl acetate found no relevant hormonal effects in cells or animals 27Reference 27ReviewCritical assessment of the endocrine potential of linalool and linalyl acetate — in-vitro/in-vivo reviewView study →. A 2020 systematic review of eleven reported cases found little to no evidence for the proposed link 30Reference 30Systematic reviewThe relationship between lavender and tea tree essential oils and pediatric endocrine disorders — systematic reviewView study →. Repeated skin use in prepubertal children is still best avoided.
Drug metabolism. In a crossover study in 16 healthy volunteers, 160 mg a day of Silexan for 11 days had no clinically relevant effect on the drug-metabolising enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 or CYP3A4 38Reference 38RCTDrug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers — randomised crossover trialView study →.
Oral contraceptives. A randomized crossover trial in 24 women found that 160 mg/day of Silexan did not change blood levels of ethinylestradiol or levonorgestrel, or reduce the pill’s effect 29Reference 29RCTNo interacting influence of the lavender oil preparation Silexan on oral contraception — randomized controlled trialView study →.
Sedatives. Combining lavender with sedative drugs could add to their effect. This is a theoretical caution, and no interaction has been shown.
Avoid the concentrated oil and oral capsules. Lavender has not been studied in pregnancy, and its constituents show some hormonal activity in cell tests, though guideline animal testing did not confirm it 23,
Culinary amounts of the dried flower and brief topical or aromatherapy use are generally regarded as low-risk. The same applies while breastfeeding.
References
- Kasper, S., et al. (2010). Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder — randomized, double-blind, placebo-controlled trial. International Clinical Psychopharmacology. https://pubmed.ncbi.nlm.nih.gov/20512042/
- Kasper, S., et al. (2014). Lavender oil preparation Silexan is effective in generalized anxiety disorder — a randomized, double-blind comparison to placebo and paroxetine. International Journal of Neuropsychopharmacology. https://pubmed.ncbi.nlm.nih.gov/24456909/
- Woelk, H., & Schläfke, S. (2010). A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder — randomized controlled trial. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/19962288/
- Kasper, S., et al. (2016). Efficacy of Silexan in mixed anxiety–depression — a randomized, placebo-controlled trial. European Neuropsychopharmacology. https://pubmed.ncbi.nlm.nih.gov/26718792/
- Kasper, S., et al. (2017). Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set — randomized controlled trial. International Clinical Psychopharmacology. https://pubmed.ncbi.nlm.nih.gov/28379882/
- Yap, W. S., et al. (2019). Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders — network meta-analysis. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/31792285/
- Dold, M., et al. (2023). Efficacy of Silexan in patients with anxiety disorders — a meta-analysis of randomized, placebo-controlled trials. European Archives of Psychiatry and Clinical Neuroscience. https://pubmed.ncbi.nlm.nih.gov/36717399/
- Gastpar, M., et al. (2017). Silexan does not cause withdrawal symptoms even when abruptly discontinued — randomized controlled trial. International Journal of Psychiatry in Clinical Practice. https://pubmed.ncbi.nlm.nih.gov/28319423/
- von Känel, R., et al. (2021). Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders — meta-analysis. Brain and Behavior. https://pubmed.ncbi.nlm.nih.gov/33638614/
- Bartova, L., et al. (2023). Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety — meta-analysis. European Archives of Psychiatry and Clinical Neuroscience. https://pubmed.ncbi.nlm.nih.gov/35262795/
- Seifritz, E., et al. (2022). Effect of the anxiolytic drug silexan on sleep — a narrative review. The World Journal of Biological Psychiatry. https://pubmed.ncbi.nlm.nih.gov/36259937/
- Shen, H., et al. (2026). The sleep-enhancing effect of lavender essential oil in adults — a systematic review and meta-analysis. Holistic Nursing Practice. https://pubmed.ncbi.nlm.nih.gov/40600743/
- Xu, K., et al. (2024). Effects of aromatherapy on sleep quality in older adults — a meta-analysis. Medicine. https://pubmed.ncbi.nlm.nih.gov/39654196/
- Baldinger, P., et al. (2014). Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain — a randomized, placebo-controlled PET study. International Journal of Neuropsychopharmacology. https://pubmed.ncbi.nlm.nih.gov/25522403/
- López, V., et al. (2017). Exploring pharmacological mechanisms of lavender (Lavandula angustifolia) essential oil on central nervous system targets — in vitro. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/28579958/
- Chioca, L. R., et al. (2013). Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABA-A/benzodiazepine neurotransmission — animal model. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/23524167/
- Peana, A. T., et al. (2002). Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils — rat model. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/12587692/
- Peana, A. T., et al. (2006). Involvement of adenosine A1 and A2A receptors in (−)-linalool-induced antinociception — animal model. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/16343551/
- Peana, A. T., et al. (2004). Effects of (−)-linalool in the acute hyperalgesia induced by carrageenan, L-glutamate and prostaglandin E2 — rat model. European Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/15336945/
- Koto, R., et al. (2006). Linalyl acetate as a major ingredient of lavender essential oil relaxes the rabbit/rat smooth muscle — in vitro/animal model. Journal of Cardiovascular Pharmacology. https://pubmed.ncbi.nlm.nih.gov/16891914/
- Lis-Balchin, M., & Hart, S. (1999). Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia) — in vitro smooth-muscle study. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/10479772/
- Xu, P., et al. (2016). Protective effect of lavender oil on scopolamine-induced cognitive deficits in mice — animal model. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/27558947/
- Henley, D. V., et al. (2007). Prepubertal gynecomastia linked to lavender and tea tree oils — case series with in-vitro endocrine assays. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/17267908/
- Diaz, A., et al. (2016). Prepubertal gynecomastia and chronic lavender exposure — report of three cases. Journal of Pediatric Endocrinology and Metabolism. https://pubmed.ncbi.nlm.nih.gov/26353172/
- Ramsey, J. T., et al. (2019). Lavender products associated with premature thelarche and prepubertal gynecomastia — case reports and in-vitro endocrine-disruptor screening. Journal of Clinical Endocrinology and Metabolism. https://pubmed.ncbi.nlm.nih.gov/31393563/
- Politano, V. T., et al. (2013). Uterotrophic assay of percutaneous lavender oil in immature female rats — animal model (negative). International Journal of Toxicology. https://pubmed.ncbi.nlm.nih.gov/23358464/
- Hareng, L., et al. (2024). Critical assessment of the endocrine potential of linalool and linalyl acetate — in-vitro/in-vivo review. Archives of Toxicology. https://pubmed.ncbi.nlm.nih.gov/37906319/
- Sharma, K., et al. (2024). Effect of essential-oil components on the activity of steroidogenic cytochrome P450 — in vitro. Biomolecules. https://pubmed.ncbi.nlm.nih.gov/38397440/
- Heger-Mahn, D., et al. (2014). No interacting influence of the lavender oil preparation Silexan on oral contraception — randomized controlled trial. Drugs in R&D. https://pubmed.ncbi.nlm.nih.gov/25319228/
- Hawkins, J., et al. (2020). The relationship between lavender and tea tree essential oils and pediatric endocrine disorders — systematic review. Complementary Therapies in Medicine. https://pubmed.ncbi.nlm.nih.gov/32147050/
- Peana, A. T., et al. (2006). (−)-Linalool inhibits in vitro NO formation: probable involvement in the antinociceptive activity — in vitro/animal model. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/16137709/
- ISO 3515:2002. Oil of lavender (Lavandula angustifolia Mill.). International Organization for Standardization. (Gas-chromatographic composition limits.)
- Cavanagh, H. M. A., & Wilkinson, J. M. (2002). Biological activities of lavender essential oil — review. Phytotherapy Research, 16(4), 301–308.
- Missouri Botanical Garden Plant Finder — Lavandula angustifolia — [botanical/distribution reference]. https://www.missouribotanicalgarden.org/plantfinder/PlantFinderDetails.aspx?taxonid=281393
- North Carolina State University Extension. Lavandula angustifolia (English lavender) — plant profile — NC State Extension Gardener Plant Toolbox. https://plants.ces.ncsu.edu/plants/lavandula-angustifolia/
- Hedge, I. C. Lavandula angustifolia Mill. — species description and distribution — flora. In Flora of Pakistan, Labiatae. http://www.efloras.org/florataxon.aspx?flora_id=5&taxon_id=200019757
- Li, X. W., & Hedge, I. C. Lavandula angustifolia Miller — species description and distribution — flora. In Wu, Z. Y., & Raven, P. H. (eds.), Flora of China, Vol. 17 (Lamiaceae). http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=200019757
- Doroshyenko, O., Rokitta, D., Zadoyan, G., et al. (2013). Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers — randomised crossover trial. Drug Metabolism and Disposition. https://pubmed.ncbi.nlm.nih.gov/23401474/